Sodium-glucose cotransporter 2 inhibitors and cardiovascular events among patients with type 2 diabetes and low-to-normal body mass index: a nationwide cohort study

Patients with low-to-normal body mass index (BMI;

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cardiovascular Diabetology 2024-10, Vol.23 (1), p.372-10, Article 372
Hauptverfasser:	Mori, Yuichiro, Komura, Toshiaki, Adomi, Motohiko, Yagi, Ryuichiro, Fukuma, Shingo, Kondo, Naoki, Yanagita, Motoko, Duru, O Kenrik, Tuttle, Katherine R, Inoue, Kosuke
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Body Mass Index Cardiac patients Cardiovascular Diseases - diagnosis Cardiovascular Diseases - epidemiology Cardiovascular Diseases - mortality Cardiovascular Diseases - prevention & control Databases, Factual Dextrose Diabetes Mellitus, Type 2 - diagnosis Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - epidemiology Diabetes therapy Dipeptidyl-Peptidase IV Inhibitors - adverse effects Dipeptidyl-Peptidase IV Inhibitors - therapeutic use Female Glucose Heart attack Heart Disease Risk Factors Humans Incidence Japan - epidemiology Male Middle Aged Proteases Retrospective Studies Risk Assessment Risk Factors Sodium-Glucose Transporter 2 Inhibitors - adverse effects Sodium-Glucose Transporter 2 Inhibitors - therapeutic use Time Factors Treatment Outcome Type 2 diabetes
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Patients with low-to-normal body mass index (BMI;
ISSN:	1475-2840 1475-2840
DOI:	10.1186/s12933-024-02478-7